Personal Care Products(IN20289.HK)

Last Updated 08:00:00
longbridge loading
Company Encyclopedia
View More
name
Personal Care Products
IN20289.HK
News
View More

Giant Biogene Wins China Approval for World-First Collagen–Hyaluronate Skin Implant

Giant Biogene Holding Co. Ltd. has received approval in China for its Recombinant Type I α1 Subtype Collagen and Sodium Hyaluronate Composite Solution, the first of its kind for intradermal injection aimed at improving cheek smoothness. This product enhances the company's collagen portfolio and is expected to create new market opportunities in skin rejuvenation. The current analyst rating for Giant Biogene's stock (HK:2367) is a Hold with a price target of HK$39.50.

Tip Ranks·
HK
02367
+2.33%
Tip Ranks·
HK
02367
+2.33%

Giant Biogene Holding Co. Ltd. (2367) Receives a Buy from Guotai Haitong

Guotai Haitong analyst maintained a Buy rating on Giant Biogene Holding Co. Ltd. yesterday and set a price target of HK$43.60.Claim 70% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential The word on The Street in general, suggests a Strong Buy analyst consensus rating for Giant Biogene Holding Co. Ltd. with a HK$52.50 average price target.

Tip Ranks·
HK
02367
+2.33%
Tip Ranks·
HK
02367
+2.33%

Numans Health Buys Lenovo Shares

Numans Health Buys Lenovo Shares

marketscreener·
HK
02530
+1.72%
marketscreener·
HK
02530
+1.72%

Numans Health Food Holdings Company Limited (HKG:2530) Stock's On A Decline: Are Poor Fundamentals The Cause?

Numans Health Food Holdings (HKG:2530) has seen an 11% decline in stock price, attributed to weak fundamentals. The company's return on equity (ROE) stands at 6.4%, significantly below the industry average of 11%. Over the past five years, net income has dropped by 19%, while the industry experienced 14% growth. The high payout ratio of 76% limits reinvestment in the business, contributing to stagnant earnings. Investors should exercise caution due to the company's low ROE and lack of growth potential.

Simplywall·
HK
02530
+1.72%
Simplywall·
HK
02530
+1.72%

Butong Group Launches New Share Award Scheme

Butong Group has launched a Share Award Scheme effective for 10 years starting January 12, 2026. The scheme will utilize existing shares and will not issue new ones. Eligible participants include directors, employees, and service providers, excluding certain financial and professional advisors. The scheme is managed by Futu Trustee Limited under a trust deed, with cash contributions from the company or designated parties. This announcement was published via the Hong Kong Stock Exchange.

Reuters·
HK
06090
-2.69%
Reuters·
HK
06090
-2.69%
Posts
View More

$INSILICO(03696.HK) first all in this, then top up $FOREST CABIN(02657.HK)

$BLOKS(00325.HK)$MAO GEPING(01318.HK) Thanks again to Longbridge, the IPO was very enjoyable 😆😆😆 There are still two certain opportunities, Mixue Ice City and KAYOU

  • 0
  • 1

$HERBS GROUP(02593.HK) After the rebound high in the dark pool, it feels like it's time to sell. Local stocks have a decent gain.

  • 0
© 2026 Longbridge｜Disclaimer